AAgilent Technologies Inc.
$132.42
$2.16
(1.66%)
EarningsAug 26
Mkt Cap$36.79B
Vol756,374.00
Agilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
Agilent Technologies Inc. (NYSE: A) today announced that it has received U.S. Food and Drug Administration (FDA) approval for the PDL1 IHC 288 pharmDx assay as a companion diagnostic to identify patients with esophageal squamous cell carcinoma (ESCC), gastric, gastroesophageal junction (GEJ), and...
Business Wire
Agilent Technologies Breaks Above 200-Day Moving Average - Bullish for A
In trading on Thursday, shares of Agilent Technologies, Inc. (Symbol: A) crossed above their 200 day moving average of $130.73, changing hands as high as $132.82 per share. Agilent Technologies, Inc. shares are currently trading up about 2.4% on the day. The chart below shows...
Nasdaq News: Markets
Agilent Strengthens Biopharma Growth Prospects With AI Expansion
A enhances AI-powered lab software, automation and digital workflows to support drug discovery, biopharma research and long-term growth.
Zacks
Agilent Expands Altura Portfolio with Inert Size Exclusion and PLRP-S Columns for Biotherapeutic Analysis
Agilent Technologies Inc. (NYSE: A) today announced the latest expansion of its Altura HPLC column portfolio with the introduction of Altura size exclusion chromatography (SEC) and Altura PLRP-S columns, designed to support critical analytical workflows in biopharmaceutical development and...
Business Wire
Agilent Launches AI-Driven Analysis Module for Agilent xCELLigence RTCA eSight
Agilent Technologies Inc. (NYSE: A) today announced the launch of Agilent xCELLigence RTCA eSight AI, a new AI-powered software module that simplifies label-free imaging analysis by reducing manual cell segmentation steps and parameter tuning and supporting more consistent results. The software...
Business Wire
Why Is Agilent (A) Up 0.1% Since Last Earnings Report?
Agilent (A) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks
Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler
Agilent Technologies, Inc. (A) Initiated at Neutral With $150 Price Target by Piper Sandler...
Yahoo! Finance: News
Agilent Completes Acquisition of Biocare Medical
Agilent Technologies Inc. (NYSE: A) today announced the successful completion of its previously announced acquisition of Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP. Following the close of the transaction...
Business Wire
Is the Options Market Predicting a Spike in Agilent Technologies Stock?
Investors need to pay close attention to A stock based on the movements in the options market lately.
Zacks
Strength in Technology Enabled Products Drives Roper: Can the Momentum Sustain?
ROP's Technology Enabled Products segment is benefiting from medical product demand, helping support its 2026 growth outlook.
Zacks
<
1
2
...
>
Advertisement|Remove ads.
Latest A News
ViewAgilent Receives FDA Approval for PD-L1 IHC 28-8 pharmDx in Esophageal Squamous Cell Carcinoma (ESCC), Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinoma
Business Wire
Agilent Technologies Breaks Above 200-Day Moving Average - Bullish for A
Nasdaq News: Markets
Agilent Strengthens Biopharma Growth Prospects With AI Expansion
Zacks
Advertisement|Remove ads.